- Home
- PHAR vs QSI Comparison
PHAR vs QSI Comparison
Compare PHAR & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- QSI
- Stock Information
- Founded
- PHAR 1988
- QSI 2013
- Country
- PHAR Netherlands
- QSI United States
- Employees
- PHAR N/A
- QSI N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- PHAR Health Care
- QSI Health Care
- Exchange
- PHAR Nasdaq
- QSI Nasdaq
- Market Cap
- PHAR 618.3M
- QSI 288.2M
- IPO Year
- PHAR N/A
- QSI N/A
- Fundamental
- Price
- PHAR $8.20
- QSI $1.92
- Analyst Decision
- PHAR Strong Buy
- QSI Buy
- Analyst Count
- PHAR 3
- QSI 2
- Target Price
- PHAR $27.00
- QSI $3.25
- AVG Volume (30 Days)
- PHAR 5.6K
- QSI 24.0M
- Earning Date
- PHAR 03-13-2025
- QSI 02-27-2025
- Dividend Yield
- PHAR N/A
- QSI N/A
- EPS Growth
- PHAR N/A
- QSI N/A
- EPS
- PHAR N/A
- QSI N/A
- Revenue
- PHAR $285,745,000.00
- QSI $2,266,000.00
- Revenue This Year
- PHAR $20.08
- QSI $193.90
- Revenue Next Year
- PHAR $9.22
- QSI $173.18
- P/E Ratio
- PHAR N/A
- QSI N/A
- Revenue Growth
- PHAR 30.64
- QSI 232.26
- 52 Week Low
- PHAR $6.65
- QSI $0.61
- 52 Week High
- PHAR $13.20
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- PHAR 36.29
- QSI 42.87
- Support Level
- PHAR $8.49
- QSI $2.26
- Resistance Level
- PHAR $9.35
- QSI $2.12
- Average True Range (ATR)
- PHAR 0.55
- QSI 0.25
- MACD
- PHAR -0.17
- QSI -0.11
- Stochastic Oscillator
- PHAR 12.14
- QSI 7.53
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.